BioLineRx Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to BioLineRx Reports Second Quarter 2022 Financial Results and Provides Corporate Update
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.16 -0.13 (3.95%)
Previous Close $3.29    52 Week High $1.63 
Open $3.25    52 Week Low $0.71 
Day High $3.28    P/E N/A 
Day Low $3.15    EPS $0.00 
Volume 13,485       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.16 -0.13 (3.95%)
Previous Close $3.29    52 Week High $1.63 
Open $3.25    52 Week Low $0.71 
Day High $3.28    P/E N/A 
Day Low $3.15    EPS $0.00 
Volume 13,485